Xvivo Perfusion AB (publ) (Xvivo) reports its Q2 2026 results and discusses them during an earnings call. According to the provided sources, the company’s reporting covers its financial performance for the quarter and includes management’s commentary on the business outlook. The Seeking Alpha materials reference both a transcript of the Q2 2026 earnings call and a separate summary of the Q2 results. However, the content provided here does not include specific financial figures (such as revenue, profitability, cash flow, or guidance), nor does it include detailed operational updates (such as customer wins, product development milestones, or geography-specific performance). As a result, the available information confirms the timing and existence of the Q2 2026 results release and the accompanying earnings call, but it does not allow for verification of particular metrics or claims across outlets. Overall, the sources indicate that investors receive both a formal results release and management commentary through the earnings call format.